Spotlight: Nov 1, 2026
Engineers have developed a nanoscale particle for delivering personalized cancer vaccines. The particle could be adapted to carry many different antigens, to potentially prevent or treat individual patients’ tumors.
Engineers have developed a nanoscale particle for delivering personalized cancer vaccines. The particle could be adapted to carry many different antigens, to potentially prevent or treat individual patients’ tumors.
Engineers designed a robotic enteroscope that can move easily through the narrow passage of the small intestine. They hope to deploy it to perform imaging, deliver drugs, and remove small polyps or tissue samples for biopsy.
Founded by Jake Jurewicz ’14, SM ’15, Blue Energy manufactures giant pieces of nuclear reactors at shipyards and ships them on barges for final assembly. The startup aims to rejuvenate the nuclear power industry with a new manufacturing approach.
An MIT spinout is making surgical stitching more like applying tape: SanaHeal has developed a biologically compatible adhesive that sticks to wet tissues. Its product was inspired by sticky materials in nature, like barnacles and spider webs.
AI has reshaped materials science by proposing new structures. But many potential structures are stored in databases, inaccessible to large language models. To overcome this, researchers created a vision-language model for crystalline materials.
This fact sheet offers a high-level summary of the many steps MIT leaders have taken to support our vibrant Jewish community.
MIT’s vital research and education — on topics such as human health, energy innovation, quantum computing, and advanced manufacturing — continue to advance national security, economic competitiveness, and quality of life for all Americans.